The Globe and Mail reports in its Friday, May 8, edition that TD Cowen analyst Mario Mendonca is keeping his "buy" recommendation for Sun Life Financial intact. The Globe's David Leeder writes in the Eye On Equities column that Mr. Mendonca jacked his share target up by $5 to $107. Analysts on average target the shares at $101. Mr. Mendonca says in a note: "Sun Life Financial beat our estimate on stronger U.S. and Asian results. In the U.S., experience losses dropped to only nil (forecast: $25-million (U.S.)) and the dental loss ratio improved to 87.2 per cent, below Sun Life's target. Pricing actions and reserving point to better U.S. results in 2026. While MFS margins remain healthy, outflows remain elevated. Asia sales and earnings remain healthy." The Globe reported on Nov. 7 and Feb. 13 that Mr. Mendonca had reiterated his "buy" recommendation for Sun Life Financial. The shares could then be had for $82.12 and $93.94. The Globe reported on Feb. 6 that Scotia Capital analyst Mike Rizvanovic continued to rate Sun Life "sector perform." The shares were then going for $88.78.